|
|
Volumn 363, Issue 9415, 2004, Pages 1160-1162
|
|
WHO, the Global Fund, and medical malpractice in malaria treatment [2] (multiple letters)
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIMALARIAL AGENT;
ARTEMISIN;
CHLOROQUINE;
FANSIDAR;
INSECTICIDE;
LAMIVUDINE;
LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE;
NEVIRAPINE;
STAVUDINE;
UNCLASSIFIED DRUG;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
BED NET;
CHEMICAL PEST CONTROL;
DRUG ABSORPTION;
DRUG COST;
DRUG EXCRETION;
EVIDENCE BASED MEDICINE;
FINANCIAL MANAGEMENT;
FOLLOW UP;
HEALTH CARE POLICY;
HEALTH CARE SYSTEM;
HEALTH PROGRAM;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
MALARIA CONTROL;
MALARIA FALCIPARUM;
MALPRACTICE;
MEDICAL PRACTICE;
PATIENT COMPLIANCE;
PATIENT MONITORING;
PLASMODIUM FALCIPARUM;
PRIORITY JOURNAL;
PUBLIC HEALTH;
SEVERE ACUTE RESPIRATORY SYNDROME;
SIDE EFFECT;
TREATMENT OUTCOME;
WORLD HEALTH ORGANIZATION;
|
|
EID: 11144355071
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(04)15904-7 Document Type: Letter |
|
Times cited : (6)
|
|
References (2)
|
